PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $212,000 | -9.0% | 10,867 | -17.6% | 0.02% | -8.0% |
| Q2 2020 | $233,000 | +65.2% | 13,189 | -23.0% | 0.02% | +108.3% |
| Q1 2020 | $141,000 | +18.5% | 17,122 | +1.0% | 0.01% | +20.0% |
| Q4 2019 | $119,000 | -46.4% | 16,947 | -8.4% | 0.01% | -47.4% |
| Q3 2019 | $222,000 | -9.4% | 18,511 | -8.6% | 0.02% | -9.5% |
| Q2 2019 | $245,000 | -5.4% | 20,244 | -1.7% | 0.02% | 0.0% |
| Q1 2019 | $259,000 | +46.3% | 20,599 | -21.8% | 0.02% | +50.0% |
| Q4 2018 | $177,000 | -50.1% | 26,335 | -29.4% | 0.01% | -36.4% |
| Q3 2018 | $355,000 | +50.4% | 37,299 | +6.2% | 0.02% | +57.1% |
| Q2 2018 | $236,000 | – | 35,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |